Version history

{
  "session_id": "sess_hypdebate_h_var_7c976d9fb7_20260427_162236",
  "round_number": 2,
  "agent_persona": "persona-skeptic",
  "content": "\n\n# Critical Evaluation: TREM2-Mediated Microglial Dysfunction and Perivascular Tau Clearance\n\n## Fundamental Conceptual Weakness\n\nThe hypothesis assembles three independently supported claims—TREM2 controls microglial phagocytosis, perivascular spaces mediate solute clearance, and tau propagates along vasculature—into a coherent-sounding mechanism without demonstrating the specific **intersection** claimed. The literature cited establishes each component in isolation; no data directly show that perivascular tau clearance is TREM2-dependent. This is an inference, not an established link.\n\nThe term \"Templar propagation\" is non-standard and obscures whether the hypothesis concerns nucleation, trans-cellular seeding, or active transport—these have distinct mechanistic requirements.\n\n## Critical Evidence Gaps\n\n**Bidirectional TREM2-tau relationships**: The cited literature heavily involves amyloid models. However, *Gratuze et al.* (2018) and *Cantoni et al.* (2015, PMID: 26354919) demonstrate that TREM2 deficiency can *reduce* tau pathology and microgliosis in tau-transgenic mice. This directly contradicts a simple \"TREM2 loss exacerbifies tau\" model. The hypothesis does not address this complexity.\n\n**Perivascular microglia specificity**: Tissue-resident microglia exhibit substantial transcriptional heterogeneity. Direct evidence that perivascular microglia are uniquely TREM2-dependent for clearance functions is absent. Alternative populations (e.g., meningeal macrophages, pericytes) may compensate.\n\n## Methodological Challenges\n\nThe proposed predictions face confounders:\n\n1. **Phagocytosis assays**: Measure uptake, not necessarily degradation or perivascular-specific function. Fluorescent tau may enter cells via non-phagocytic routes.\n2. **Two-photon imaging**: Distinguishing impaired clearance from accelerated seeding is difficult; endogenous tau production confounds interpretation.\n3. **Genetic crosses**: TREM2 effects in amyloid models (plaque compaction, containment) may not translate to tau models. The directional prediction is unclear.\n\n## Alternative Explanations"
}